Form 4: Abbott Laboratories Executive Vice President Sells Shares

Executive Vice President of Abbott Laboratories, Louis H. Morrone, sold 2,644 common shares on January 28, 2025.

Summary

• Louis H. Morrone, an Executive Vice President at Abbott Laboratories, sold 2,644 common shares of the company on January 28, 2025.
• The shares were sold at a price of $127.39 per share.
• Following the transaction, Mr. Morrone still holds shares indirectly through a Profit Sharing Trust.
• The transaction was reported on January 30, 2025.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale, which is a common occurrence. It doesn't indicate any positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate executives who trade company stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the United States, ensuring transparency of insider trading activities.
• Similar filings are made by executives at companies like Johnson & Johnson (JNJ) and Medtronic (MDT) when they trade their company's stock.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on shareholder sentiment, but is generally considered a normal part of executive compensation and portfolio management.

Key Dates

Keywords

Abbott Laboratories, insider trading, stock sale, executive, Louis H. Morrone, ABT, share transaction